Cue Biopharma is trading 5.2% up today at $27.98, driven by broader biotech sector momentum and lingering optimism from recent corporate developments.
- The move follows sharp volatility over the past week and earlier optimism around the company’s CUE-221 licensing deal and financing.
- There are no new earnings, FDA updates, or deal announcements explicitly linked to today’s price action.